StockDrifts LogoStockDrifts

NKMAX 182400

Company
엔케이맥스NKMAX
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2025-06-26

NKMAX (182400) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for NKMAX is dated 2025-06-26; the most recent is 2025-06-26.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2025-06-26BUY주식병합
NKGenBiotech,Inc.
-46.4M₩3,670+0.0%₩170.3B ($118.3M)
2025-06-26SELL주식병합
김용만
Yongman Kim
co-manager-9.9K₩3,670+0.0%₩36M ($25K)

Frequently asked questions

Who has been buying NKMAX stock?
0 distinct insiders have filed 0 disclosed insider purchases in NKMAX (182400), most recently on 2025-06-26. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does NKMAX have?
NKMAX has 0 buy-side and 0 sell-side disclosures on record, spanning 2025-06-26 to 2025-06-26.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.